The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Medical methods for first trimester abortion
Open accessAbstract
BACKGROUND: Surgical abortion by vacuum aspiration or dilatation and curettage has been the method of choice for early pregnancy termination since the 1960s. Medical abortion became an alternative method of first trimester pregnancy termination with the availability of prostaglandins in the early 1970s and anti-progesterones in the 1980s. The most widely researched drugs are prostaglandins (PGs) alone, mifepristone alone, methotrexate alone, mifepristone with prostaglandins and methotrexate with prostaglandins. OBJECTIVES: To compare different medical methods for first trimester abortion. SEARCH METHODS: The Cochrane Controlled Trials Register, MEDLINE and Popline were systematically searched. Reference lists of retrieved papers were also searched. Experts in WHO/HRP were contacted. SELECTION CRITERIA: Types of studies Randomised controlled trials comparing different medical methods for abortion during first trimester (e.g. single drug, combination) were considered. Trials were assessed and included if they had adequate concealment of allocation, randomisation procedure and follow-up. Women, pregnant during the first trimester, undergoing medical abortion were the participants. The outcomes were mortality, failure to achieve complete abortion, surgical evacuation, ongoing pregnancy at follow-up, time until passing of conceptus, blood transfusion, side effects and women's dissatisfaction with the procedure. DATA COLLECTION AND ANALYSIS: Two reviewers independently selected trials for inclusion from the results of the search strategy described previously.The selection of trials for inclusion in the review was performed independently by two reviewers after employing the search strategy described previously. Trials under consideration were evaluated for appropriateness for inclusion and methodological quality without consideration of their results. Data were processed using Revman software. MAIN RESULTS: Fifty-eight trials were included in the review. The effectiveness outcomes below refer to 'failure to achieve complete abortion' with the intended method unless otherwise stated. 1) Combined regimen mifepristone/prostaglandin: Mifepristone 600 mg compared to 200 mg shows similar effectiveness in achieving complete abortion (4 trials, RR 1.07, 95% CI 0.87 to 1.32). Misoprostol administered orally is less effective (more failures) than the vaginal route (RR 3.00, 95% CI 1.44 to 6.24) and may be associated with more frequent side effects such as nausea and diarrhoea. Sublingual and buccal routes were similarly effective compared to the vaginal route, but had higher rates of side effects. 2) Mifepristone alone is less effective when compared to the combined regimen mifepristone/prostaglandin (RR 3.76 95% CI 2.30 to 6.15). 3) Five trials compared prostaglandin alone to the combined regimen (mifepristone/prostaglandin). All but one reported higher effectiveness with the combined regimen. The results of these studies could not be combined but the RR of failure with prostaglandin alone is reportedly between 1.4 to 3.75 with the 95% confidence intervals indicating statistical significance. 4) In one trial comparing gemeprost 0.5 mg with misoprostol 800 mcg, misoprostol was more effective (failure with gemeprost: RR 2.86, 95% CI 1.14 to 7.18). 5) There was no difference in effectiveness with use of a divided dose compared to a single dose of prostaglandin. 6) Combined regimen methotrexate/prostaglandin demonstrates similar rates of failure to complete abortion when comparing intramuscular to oral methotrexate administration (RR 2.04, 95% CI 0.51 to 8.07). Similarly, day 3 vs. day 5 administration of prostaglandin following methotrexate administration showed no significant differences (RR 0.72, 95% CI 0.36 to 1.43). One trial compared the effect of tamoxifen vs. methotrexate and no statistically significant differences were observed in effectiveness between the groups. AUTHORS' CONCLUSIONS: Safe and effective medical abortion methods are available. Combined regimens are more effective than single agents. In the combined regimen, the dose of mifepristone can be lowered to 200 mg without significantly decreasing the method effectiveness. Vaginal misoprostol is more effective than oral administration, and has less side effects than sublingual or buccal. Some results are limited by the small numbers of participants on which they are based. Almost all trials were conducted in settings with good access to emergency services, which may limit the generalizability of these results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO technical report series 200 (1960).
Pittman, M. (1974) · PubMed · Cited by 1,448
Annals of the New York Academy of Sciences
R K, &. (1950) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195006000-00023 · Cited by 1,124
Induction of Abortion with Mifepristone (RU 486) and Oral or Vaginal Misoprostol
El-Refaey, H., Rajasekar, D., Abdalla, M., Calder, L., & Templeton, A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321502 · Cited by 387
Schaff, E. A., Fielding, S. L., Westhoff, C., Ellertson, C., Eisinger, S. H., Stadalius, L. S., & Fuller, L. (2000) · JAMA · doi:10.1001/jama.284.15.1948 · Cited by 211
Winikoff, B., Sivin, I., Coyaji, K. J., Cabezas, E., Bilian, X., Sujuan, G., Ming-kun, D., Krishna, U. R., Eschen, A., & Ellertson, C. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70511-8 · Cited by 179
World Health Organisation Task Force on Post‐ovulatory Methods of Fertility Regulation Special Programme of Research, D. A. R. T. (2000) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb13273.x · Cited by 169
Ngo, T. D., Park, M. H., Shakur‐Still, H., et al. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.10.084046 · Cited by 167
Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases
Ashok, P. W., Templeton, A. A., Wagaarachchi, P. T., et al. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1046/j.1471-0528.2002.02156.x · Cited by 166
Legal Abortion Worldwide: Incidence and Recent Trends
Sedgh, G., Henshaw, S. K., Singh, S. D., Bankole, A., & Drescher, J. (2007) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3921607 · Cited by 125
Cited by
Unsafe abortion: the preventable pandemic
Grimes, D. A., Benson, J., Singh, S., Romero, M., Ganatra, B., Okonofua, F. E., & Shah, I. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69481-6 · Cited by 887
Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries
Adam, T., Lim, S. S., Mehta, S., Bhutta, Z. A., Fogstad, H., Mathai, M., Zupan, J., & Darmstadt, G. L. (2005) · BMJ · doi:10.1136/bmj.331.7525.1107 · Cited by 365
Abortion safety and use with normally prescribed mifepristone in Canada
Schummers, L., Darling, E. K., Dunn, S., McGrail, K., Gayowsky, A., Law, M. R., Laba, T.-L., Kaczorowski, J., & Norman, W. V. (2022) · New England Journal of Medicine · doi:10.1056/nejmsa2109779 · Cited by 71
Mediboina, A., Badam, R. K., & Chodavarapu, S. (2024) · Cureus · doi:10.7759/cureus.51544 · Cited by 29
Metadata
- Authors
- Kulier, R., Kapp, N., Gülmezoglu, A. M., Hofmeyr, G. J., Cheng, L., & Campana, A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2011-11-09
- Issue
- 11
- Pages
- CD002855-CD002855
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2105692450
- Cited by
- 284
- References
- 37
- FWCI
- 20.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Medical methods for first trimester abortion. https://app.cochat.ai/papers/10.1002/14651858.cd002855.pub4
- The paper
- Kulier, R., Kapp, N., Gülmezoglu, A. M., Hofmeyr, G. J., Cheng, L., & Campana, A. (2011). Medical methods for first trimester abortion. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd002855.pub4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.